11/11/2025Summit and Akeso Report Positive Phase III Results for Ivonescimab at ...

11/11/2025Nona and Umoja Expand Partnership to Advance In‑Vivo CAR‑T Cell Ther...

11/11/2025Glenmark Gains NMPA Approval for RYALTRIS®

11/11/2025Simcere to Manufacture Idorsia's Insomnia Drug in China

11/11/2025China Launches National Strategy to Integrate AI Across Healthcare Sys...

11/11/2025Chinese Innovative Drug Companies Report Strong Q3 Results

11/11/2025CDE Opens Public Consultation on Draft Guidelines for Recombinant Mono...

11/7/2025Sanofi's Cablivi Wins Approval in China as First Nanobody Therapy for ...

11/7/2025Lepu to Present Promising Phase II Data of CD20 ADC MRG001 Plus Orelab...

11/7/2025NMPA Pilots Streamlined Review Pathway for Supplemental Applications o...

11/7/2025Recent Executive Moves

11/6/2025Dermavon Files for Hong Kong IPO to Advance Innovative Skin Health Por...

11/6/2025AstraZeneca Adds CNY 990M Investment to Qingdao Inhalants Plant

11/5/2025CSL Behring Expands Partnership with Baiyang Pharma for Albumin Produc...

11/5/2025Merck Secures $700M Funding from Blackstone for TROP2-Targeting ADC C...

11/5/2025US Dollar Funds Make a Comeback in China's Innovative Drug Market: VBD...

11/5/2025CDE Grants Breakthrough Therapy Designation to Ivonescimab for Triple-...

11/5/2025China to Expand Use of Artificial Intelligence Across Health Sector by...

11/5/2025Bayer Deepens Investment in China's Booming Biopharma Sector

11/5/2025Senior CSPC Executive Fined CNY 5M for Insider Trading

11/5/2025China Expands Drug Access Through 11th National Bulk-Buy and New 2025 ...

11/5/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China

11/5/2025AbbVie's CD20×CD3 Bispecific Epcoritamab Fails to Win China Approval

11/5/2025MNCs Retreat as China Cancels Dozens of Branded Medicines Amid Price C...

11/5/2025China Wraps Up 2025 Drug Negotiation: Dual Catalogs Debut, Innovative ...

11/4/2025Everest Acquires Exclusive Greater China and Other Asian Country Right...

11/4/2025NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO

11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...

11/4/2025Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...

11/4/2025NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...

Page:2/372 Total number of articles:11148: [First][<<] [1] [2] [3] [4] [5] [>>] [End]